guest ::
| Home > User submitted records > Genomic evolution shapes prostate cancer disease type > print |
| 001 | 294791 | ||
| 005 | 20241204090648.0 | ||
| 024 | 7 | _ | |a 10.1016/j.xgen.2024.100511 |2 doi |
| 037 | _ | _ | |a DKFZ-2024-02503 |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Woodcock, Dan J. |b 0 |
| 245 | _ | _ | |a Genomic evolution shapes prostate cancer disease type |
| 260 | _ | _ | |a Amsterdam |c 2024 |b Elsevier |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1733299276_24286 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a The development of cancer is an evolutionary process involving the sequential acquisition of genetic alterations that disrupt normal biological processes, enabling tumor cells to rapidly proliferate and eventually invade and metastasize to other tissues. We investigated the genomic evolution of prostate cancer through the application of three separate classification methods, each designed to investigate a different aspect of tumor evolution. Integrating the results revealed the existence of two distinct types of prostate cancer that arise from divergent evolutionary trajectories, designated as the Canonical and Alternative evolutionary disease types. We therefore propose the evotype model for prostate cancer evolution wherein Alternative-evotype tumors diverge from those of the Canonical-evotype through the stochastic accumulation of genetic alterations associated with disruptions to androgen receptor DNA binding. Our model unifies many previous molecular observations, providing a powerful new framework to investigate prostate cancer disease progression.Keywords: AR binding; cancer evolution; evotype model; evotypes; ordering; prostate cancer. |
| 536 | _ | _ | |a 312 - Funktionelle und strukturelle Genomforschung (POF4-312) |0 G:(DE-HGF)POF4-312 |c POF4-312 |f POF IV |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, Journals: inrepo02.dkfz.de |
| 700 | 1 | _ | |a Sahli, Atef |b 1 |
| 700 | 1 | _ | |a Teslo, Ruxandra |b 2 |
| 700 | 1 | _ | |a Bhandari, Vinayak |b 3 |
| 700 | 1 | _ | |a Gruber, Andreas J. |b 4 |
| 700 | 1 | _ | |a Ziubroniewicz, Aleksandra |b 5 |
| 700 | 1 | _ | |a Gundem, Gunes |b 6 |
| 700 | 1 | _ | |a Xu, Yaobo |b 7 |
| 700 | 1 | _ | |a Butler, Adam |b 8 |
| 700 | 1 | _ | |a Anokian, Ezequiel |b 9 |
| 700 | 1 | _ | |a Pope, Bernard J. |b 10 |
| 700 | 1 | _ | |a Jung, Chol-Hee |b 11 |
| 700 | 1 | _ | |a Tarabichi, Maxime |b 12 |
| 700 | 1 | _ | |a Dentro, Stefan |0 P:(DE-He78)40af5fd3ec583f9dc5da1c7c7e00524f |b 13 |u dkfz |
| 700 | 1 | _ | |a Farmery, J. Henry R. |b 14 |
| 700 | 1 | _ | |a Van Loo, Peter |b 15 |
| 700 | 1 | _ | |a Warren, Anne Y. |b 16 |
| 700 | 1 | _ | |a Gnanapragasam, Vincent |b 17 |
| 700 | 1 | _ | |a Hamdy, Freddie C. |b 18 |
| 700 | 1 | _ | |a Bova, G. Steven |b 19 |
| 700 | 1 | _ | |a Foster, Christopher S. |b 20 |
| 700 | 1 | _ | |a Neal, David E. |b 21 |
| 700 | 1 | _ | |a Lu, Yong-Jie |b 22 |
| 700 | 1 | _ | |a Kote-Jarai, Zsofia |b 23 |
| 700 | 1 | _ | |a Fraser, Michael |b 24 |
| 700 | 1 | _ | |a Bristow, Robert G. |b 25 |
| 700 | 1 | _ | |a Boutros, Paul C. |b 26 |
| 700 | 1 | _ | |a Costello, Anthony J. |b 27 |
| 700 | 1 | _ | |a Corcoran, Niall M. |b 28 |
| 700 | 1 | _ | |a Hovens, Christopher M. |b 29 |
| 700 | 1 | _ | |a Massie, Charlie E. |b 30 |
| 700 | 1 | _ | |a Lynch, Andy G. |b 31 |
| 700 | 1 | _ | |a Brewer, Daniel S. |b 32 |
| 700 | 1 | _ | |a Eeles, Rosalind A. |b 33 |
| 700 | 1 | _ | |a Cooper, Colin S. |b 34 |
| 700 | 1 | _ | |a Wedge, David C. |b 35 |
| 773 | _ | _ | |a 10.1016/j.xgen.2024.100511 |g Vol. 4, no. 3, p. 100511 - |0 PERI:(DE-600)3110160-4 |n 3 |p 100511 - |t Cell genomics |v 4 |y 2024 |x 2666-979X |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 13 |6 P:(DE-He78)40af5fd3ec583f9dc5da1c7c7e00524f |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-312 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Funktionelle und strukturelle Genomforschung |x 0 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2023-08-29 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2023-08-29 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0320 |2 StatID |b PubMed Central |d 2023-08-29 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0501 |2 StatID |b DOAJ Seal |d 2023-05-09T12:14:04Z |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0500 |2 StatID |b DOAJ |d 2023-05-09T12:14:04Z |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b DOAJ : Double anonymous peer review |d 2023-05-09T12:14:04Z |
| 915 | _ | _ | |a Article Processing Charges |0 StatID:(DE-HGF)0561 |2 StatID |d 2023-08-29 |
| 915 | _ | _ | |a Fees |0 StatID:(DE-HGF)0700 |2 StatID |d 2023-08-29 |
| 920 | 1 | _ | |0 I:(DE-He78)B450-20160331 |k B450 |l Künstl. Intelligenz in der Onkologie |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a USER |
| 980 | _ | _ | |a VDBRELEVANT |
| 980 | _ | _ | |a I:(DE-He78)B450-20160331 |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|